- Home
- PPSI vs COEP Comparison
PPSI vs COEP Comparison
Compare PPSI & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPSI
- COEP
- Stock Information
- Founded
- PPSI 2008
- COEP 2017
- Country
- PPSI United States
- COEP United States
- Employees
- PPSI N/A
- COEP N/A
- Industry
- PPSI Electrical Products
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PPSI Industrials
- COEP Health Care
- Exchange
- PPSI Nasdaq
- COEP Nasdaq
- Market Cap
- PPSI 30.0M
- COEP 27.4M
- IPO Year
- PPSI N/A
- COEP N/A
- Fundamental
- Price
- PPSI $2.88
- COEP $10.72
- Analyst Decision
- PPSI Strong Buy
- COEP
- Analyst Count
- PPSI 1
- COEP 0
- Target Price
- PPSI $12.00
- COEP N/A
- AVG Volume (30 Days)
- PPSI 71.1K
- COEP 59.4K
- Earning Date
- PPSI 08-14-2025
- COEP 08-15-2025
- Dividend Yield
- PPSI 51.55%
- COEP N/A
- EPS Growth
- PPSI N/A
- COEP N/A
- EPS
- PPSI 2.84
- COEP N/A
- Revenue
- PPSI $26,304,000.00
- COEP $62,874.00
- Revenue This Year
- PPSI $24.01
- COEP N/A
- Revenue Next Year
- PPSI $19.25
- COEP N/A
- P/E Ratio
- PPSI $1.02
- COEP N/A
- Revenue Growth
- PPSI 439.46
- COEP N/A
- 52 Week Low
- PPSI $2.25
- COEP $2.31
- 52 Week High
- PPSI $7.00
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- PPSI 43.38
- COEP 55.11
- Support Level
- PPSI $3.51
- COEP $11.30
- Resistance Level
- PPSI $3.94
- COEP $11.46
- Average True Range (ATR)
- PPSI 0.28
- COEP 0.95
- MACD
- PPSI -0.05
- COEP -0.05
- Stochastic Oscillator
- PPSI 14.52
- COEP 38.82
About PPSI Pioneer Power Solutions Inc.
Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.